These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9413198)

  • 1. Characteristics of human gastric carcinoma cell lines with induced multidrug resistance.
    Kang MS; Kim HS; Han JA; Park SC; Kim WB; Park JG
    Anticancer Res; 1997; 17(5A):3531-6. PubMed ID: 9413198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
    Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
    Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
    Gai XD; Li GL; Huang JZ; Xue HJ; Wang D
    Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
    Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
    Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y; Takano H; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F; Hou YQ; Song Y; Yuan ZJ
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of drug-induced dysregulations among seven resistance-associated genes in human tumour cell lines.
    Van Hille B; Lohri A; Reuter J; Herrmann R
    Anticancer Res; 1996; 16(6B):3531-6. PubMed ID: 9042217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
    Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.
    Cocker HA; Pinkerton CR; Kelland LR
    Br J Cancer; 2000 Aug; 83(3):338-45. PubMed ID: 10917549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.
    Mestdagh N; Pommery N; Saucier JM; Hecquet B; Fournier C; Slomianny C; Teissier E; Hénichart JP
    Anticancer Res; 1994; 14(3A):869-74. PubMed ID: 7915509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
    Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity, expression of Bcl-2 and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines.
    Yoon KA; Ku JL; Yang JO; Park JG
    Int J Mol Med; 2003 Mar; 11(3):343-8. PubMed ID: 12579337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
    Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of O⁶-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells.
    Raguz S; Adams C; Masrour N; Rasul S; Papoutsoglou P; Hu Y; Cazzanelli G; Zhou Y; Patel N; Coombes C; Yagüe E
    Biochem Pharmacol; 2013 Jan; 85(2):186-96. PubMed ID: 23122841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells.
    Morrow CS; Smitherman PK; Diah SK; Schneider E; Townsend AJ
    J Biol Chem; 1998 Aug; 273(32):20114-20. PubMed ID: 9685354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.